Blueprint Medicines Corp Annual Share-based Payment Arrangement, Expense in USD from 2013 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Blueprint Medicines Corp quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2013 to 2024.
  • Blueprint Medicines Corp Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $28.4M, a 25.7% increase year-over-year.
  • Blueprint Medicines Corp Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $109M, a 17.5% increase year-over-year.
  • Blueprint Medicines Corp annual Share-based Payment Arrangement, Expense for 2024 was $109M, a 17.5% increase from 2023.
  • Blueprint Medicines Corp annual Share-based Payment Arrangement, Expense for 2023 was $92.7M, a 6.36% decline from 2022.
  • Blueprint Medicines Corp annual Share-based Payment Arrangement, Expense for 2022 was $99M, a 8.01% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.